Type 2-diabetes - Sundhedsstyrelsen

539
Effect of intensive blood-glucose control with metformin on complications in overweight
patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study
(UKPDS) Group. Lancet 1998;854-865.
540
Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S et al. Intensive insulin
therapy prevents the progression of diabetic microvascular complications in Japanese
patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6year
study. Diabetes Res Clin Pract 1995;103-117.
541
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of
glycaemia with macrovascular and microvascular complications of type 2 diabetes
(UKPDS 35): prospective observational study. BMJ 2000;405-412.
542
Wright A, Burden AC, Paisey RB, Cull CA, Holman RR. U.K. Prospective Diabetes Study
Group. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients
with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabet
Care 2002; 25:330-336.
543
McCormack J, Greenhalgh T. Seeing what you want to see in randomised controlled
trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes
study. BMJ 2000;1720-1723.
544
Meigs JB, Nathan DM, Wilson PW, Cupples LA, Singer DE. Metabolic risk factors worsen
continuously across the spectrum of nondiabetic glucose tolerance. The Framingham
Offspring Study. Ann Intern Med 1998;524-533.
545
Laakso M. Glycemic control and the risk for coronary heart disease in patients with
non-insulin-dependent diabetes mellitus. The Finnish studies. Ann Intern Med 1996;127-
130.
546
Knatterud GL, Klimt CR, Levin ME, Jacobson ME, Goldner MG. Effects of hypoglycemic
agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and
selected nonfatal events with insulin treatment. JAMA 1978;37-42.
547
Adverse events and their association with treatment regimens in the diabetes control
and complications trial. Diabet Care 1995;1415-1427.
548
1999 World Health Organization-International Society of Hypertension Guidelines for
the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999;151-
183.
549
Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting
type 2 diabetic patients and the association with risk factors for cardiovascular
and diabetic complications. J Hypertens 1993;309-317.
TYPE 2-DIABETES – Medicinsk teknologivurdering af screening, diagnostik og behandling 379